Name: 1-(Bromomethyl)-2-iodobenzene. The reaction of aromatic heterocyclic molecules with protons is called protonation. Aromatic heterocycles are more basic than benzene due to the participation of heteroatoms. Compound: 1-(Bromomethyl)-2-iodobenzene, is researched, Molecular C7H6BrI, CAS is 40400-13-3, about Synthesis of a 1,2,3-bistriazole derivative of embelin and evaluation of its effect on high-fat diet fed-streptozotocin-induced type 2 diabetes in rats and molecular docking studies. Author is Stalin, Antony; Kandhasamy, Subramani; Kannan, Balakrishnan Senthamarai; Verma, Rama Shanker; Ignacimuthu, Savarimuthu; Kim, Yrjala; Shao, Qingsong; Chen, Yuan; Palani, Perumal.
The embelin derivative I was synthesized with the 1,2,3-bistriazole and spectral data confirmed its structural identity. Anti-diabetic and anti-lipidemic effects were evaluated using HFD-STZ induced type 2 diabetic rats. The derivative I (30 mg/kg b weight) supplementation significantly (P ≤ 0.01) normalized the changed biochem. parameters like fasting blood glucose (FBG), body weights, plasma insulin level, total cholesterol (TC), triglycerides (TG) and marker enzymes of carbohydrate metabolism The derivative I (30 mg/kg) also showed a significant effect on oral glucose tolerance test (OGTT) and i.p. insulin tolerance test (ITT). But 15 mg/kg dose of derivative I failed to show any significant effects in HFD-STZ induced type 2 diabetic rats. Histopathol. anal. substantiated the protective effect of this derivative I (30 mg/kg b weight) on the β-cells of the pancreatic, liver and adipose tissues in diabetic treated rats. Further, the expressions of PPARγ and GLUT4 were significantly enhanced in the epididymal adipose tissue. The HOMO and LUMO energies characterized the mol. stability of the derivative I with 6-311G++ (d, p) in DFT/B3LYP/LanL2DZ method using Gaussian09 program package. The mol. docking anal. also confirmed the activity of derivative I through hydrogen bond interaction with ARG 288, GLU 343, SER 342 and least energy value (-7.72 kcal/mol). Hence, the embelin-1,2,3-bis triazole derivative I (30 mg/kg) enhanced the activity of embelin and might be acting as a suitable drug for type 2 diabetes, obesity and its complications.
Here is a brief introduction to this compound(40400-13-3)Name: 1-(Bromomethyl)-2-iodobenzene, if you want to know about other compounds related to this compound(40400-13-3), you can read my other articles.
Reference:
Phosphine ligand,
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate